Abstract

Research Article

A pilot study on treatment of infantile cystinosis with mesenchymal stem cells

Faysal Gok*, Cengiz Zeybek, Ayse Balat and Olcay Y Jones

Published: 09 December, 2019 | Volume 3 - Issue 3 | Pages: 181-185

Infantile cystinosis is a lysosomal storage disease leading to end stage kidney disease at early ages. There is no effective treatment and patients require long term dialysis or kidney transplant for survival. We present our experience on three affected children who received HLA matched allogeneic stem cell transplant. The protocol used was novel and designed to promote engraftment. The primary endpoint was safety for treatment related mortality or morbidity; All three children survived without serious adverse effects during extended follow up for over 4 years. Although we could not prove engraftment, all three children met secondary end point of sustained target functions over a 6 month follow-up. Further studies are warranted to further evaluate safety and efficacy of MSC treatment for infantile cystinosis.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001046 Cite this Article Read Full Article PDF

References

  1. Ruivo R. Anne C, Sagne C, Gasnier B. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochem Biophys Acta. 2009; 1793: 636–649. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19146888
  2. Sansanwal P, Sarwal MM. Abnormal mitochondrial autophagy in nephropathic cystinosis. Autophagy. 2010; 6: 971-973. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20729635
  3. Anikster Y, Shotelersuk V, Gahl WA. CTNS mutations in patients with cystinosis. Hum Mutat. 1999; 14: 454–458. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10571941
  4. Attard M, Jean G, Forestier L, Cherqui S, van't Hoff W, et al. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet. 1999; 8: 2507–2514. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10556299
  5. Gahl WA, Thoene JG, Schneider JA. Cystinosis. New Engl J Med. 2002; 347: 111–121. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12110740
  6. Goldman H, Scriver CR, Aaron K, Delvin E, Canlas Z. Adolescent cystinosis: comparisons with infantile and adult forms. Pediatrics. 1971; 47: 979–988. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/5141767
  7. Cogan DG, Kuwabara T, Kinoshita J, Sheehan L, Merola L. Cystinosis in an adult. J Am Med Assoc. 1957; 164: 394–396. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/13415995
  8. Brodin-Sartorius A, Tete MJ, Niaudet P, Antignac C, Guest G, et al. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int. 2012; 81: 179–189. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21900880
  9. Rocca CJ, Cherqui S. Potential use of stem cells as a therapy for cystinosis. Pediatr Nephrol. 2019; 34: 965-973. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29789935
  10. Cahill RA, Jones OY, Klemperer M, Steele A, Mueller TO, et al. Replacement of recipient stromal/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells. Biol Blood Marrow Transplant. 2004; 10: 709-717. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15389437
  11. Syres K, Harrison F, Tadlock M, Jester JV, Simpson J, et al. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood. 2009; 114: 2542–2552. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19506297
  12. Iglesias DM, El-Kares R, Taranta A, Bellomo F, Emma F, et al. Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cy stine Accumulation In vitro. PLoS One. 2012; 7: e42840. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22912749

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?